When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
<azithromycin, mechanism, atorvastatin>, <azithromycin, mechanism, carbamazepine>, <azithromycin, mechanism, cetirizine>, <azithromycin, mechanism, didanosine>, <azithromycin, mechanism, efavirenz>, <azithromycin, mechanism, fluconazole>, <azithromycin, mechanism, indinavir>, <azithromycin, mechanism, midazolam>, <azithromycin, mechanism, rifabutin>, <azithromycin, mechanism, sildenafil>, <azithromycin, mechanism, theophylline>, <azithromycin, mechanism, triazolam>, <azithromycin, mechanism, trimethoprim>, <azithromycin, mechanism, sulfamethoxazole>, <azithromycin, mechanism, zidovudine>